(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÕES FARMACÊUTICAS E SEUS USOS NO TRATAMENTO E PREVENÇÃO DA ESCLEROSE LATERAL AMIOTRÓFICA, E SERINGA OU BOMBA

Em ExigênciaInvention PatentPCT · US2019065936

Application data

Number

112021011334

Type

Invention Patent

Filing

12/12/2019

Publication

09/08/2021

PCT

US2019065936

Progress at the INPI

Technical opinion to answer
  1. Filing12/12/19
  2. Publication09/08/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 04/22/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BIOGEN MA INC.

US

IONIS PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

D. N. (pessoa física)

US

I. N. (pessoa física)

US

T. F. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/779,916 · 12/14/2018

US

62/807,603 · 02/19/2019

US

62/840,879 · 04/30/2019

Abstract

COMPOSIÇÕES E MÉTODOS PARA TRATAMENTO E PREVENÇÃO DA ESCLEROSE LATERAL AMIOTRÓFICA.Os regimes de dosagem para oligonucleotídeos antissenso direcionados a SOD1 e sais dos mesmos são fornecidos. Estes regimes de dosagem encontram uso no tratamento de indivíduos com ou em risco de desenvolver esclerose lateral amiotrófica.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

04/22/2026

RPI 2885

Transferência deferida

#25.1

12/02/2025

RPI 2865

Notificação de entrada na fase nacional - PCT

#1.3

09/08/2021

RPI 2644

Alteração de dados cadastrais

#1.1

06/22/2021

RPI 2633

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.